[{"id":"a2663035-0db5-4a1d-8164-60f1d9f3d378","acronym":"","url":"https://clinicaltrials.gov/study/NCT01105169","created_at":"2021-01-18T04:22:27.086Z","updated_at":"2024-07-02T16:35:44.570Z","phase":"","brief_title":"Precision-Based Magnesium Trial","source_id_and_acronym":"NCT01105169","lead_sponsor":"Vanderbilt University Medical Center","biomarkers":" CRP • MT-CO2","pipe":" | ","alterations":" PTGS2 expression","tags":["CRP • MT-CO2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PTGS2 expression"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 265","initiation":"Initiation: 08/01/2010","start_date":" 08/01/2010","primary_txt":" Primary completion: 07/01/2024","primary_completion_date":" 07/01/2024","study_txt":" Completion: 07/01/2024","study_completion_date":" 07/01/2024","last_update_posted":"2023-06-28"},{"id":"0c4d393e-bd17-43ea-b59d-e574dac72e96","acronym":"","url":"https://clinicaltrials.gov/study/NCT00118040","created_at":"2021-01-18T00:23:46.454Z","updated_at":"2024-07-02T16:36:29.291Z","phase":"Phase 2","brief_title":"Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer","source_id_and_acronym":"NCT00118040","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" EGFR • BIRC5 • CASP3 • MT-CO2","pipe":" | ","alterations":" EGFR mutation","tags":["EGFR • BIRC5 • CASP3 • MT-CO2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation"],"overall_status":"Completed","enrollment":" Enrollment 60","initiation":"Initiation: 06/24/2005","start_date":" 06/24/2005","primary_txt":" Primary completion: 08/15/2010","primary_completion_date":" 08/15/2010","study_txt":" Completion: 08/15/2010","study_completion_date":" 08/15/2010","last_update_posted":"2021-06-10"}]